Albireo Pharma (ALBO) PT Raised to $68 at Cowen; CHMP Nod Bodes Well for Upcoming PDUFA
Tweet Send to a Friend
Cowen analyst Ritu Baral raised the price target on Albireo Pharma (NASDAQ: ALBO) to $68.00 (from $65.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
